Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches
Sanfilippo syndrome or mucopolysaccharidosis III is a lysosomal storage disorder caused by mutations in genes responsible for the degradation of heparan sulfate, a glycosaminoglycan located in the extracellular membrane. Undegraded heparan sulfate molecules accumulate within lysosomes leading to cel...
Main Authors: | Noelia Benetó, Lluïsa Vilageliu, Daniel Grinberg, Isaac Canals |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/21/7819 |
Similar Items
-
An Engineered <i>sgsh</i> Mutant Zebrafish Recapitulates Molecular and Behavioural Pathobiology of Sanfilippo Syndrome A/MPS IIIA
by: Alon M. Douek, et al.
Published: (2021-05-01) -
Disease progression in Sanfilippo type B: Case series of Brazilian patients
by: Yorran Hardman Araújo Montenegro, et al.
Published: (2024-03-01) -
Perioperative care of a child with Sanfilippo syndrome for ade- notonsillectomy
by: I. Bekiroglu, et al.
Published: (2021-05-01) -
Sanfilippo syndrome: consensus guidelines for clinical care
by: Nicole Muschol, et al.
Published: (2022-10-01) -
Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III
by: Min-Sun Kim, et al.
Published: (2022-04-01)